Ocular Manifestations of Diabetes Mellitus

Overview

Classification of Ocular Manifestations

1. Diabetic Retinopathy (DR)

A. Non-Proliferative Diabetic Retinopathy (NPDR)

• Microaneurysms: earliest clinical sign — small, round, red dots; saccular outpouchings of retinal capillaries at areas of pericyte loss

• Microaneurysms + dot-blot hemorrhages
• Hard exudates: yellowish-white, waxy deposits with sharp margins; composed of lipoproteins and lipid-laden macrophages; arranged in a circinate pattern around leaking vessels
• Cotton wool spots (soft exudates): fluffy white patches due to nerve fiber layer infarctions from capillary occlusion

• 4 quadrants of intraretinal hemorrhages (diffuse)
• 2 quadrants of venous beading
• 1 quadrant of IRMA (Intraretinal Microvascular Abnormalities)

B. Proliferative Diabetic Retinopathy (PDR)

• Vitreous hemorrhage — sudden painless visual loss
• Tractional retinal detachment — fibrovascular membranes contract and pull the retina
• Neovascular glaucoma — NVI progresses to angle neovascularization, blocking aqueous outflow

• NVD ≥ 1/4–1/3 disc area
• Any NVD with vitreous/preretinal hemorrhage
• NVE ≥ 1/2 disc area + vitreous/preretinal hemorrhage

2. Diabetic Macular Edema (DME)

• Retinal thickening within 500 µm of foveal center
• Hard exudates within 500 µm of foveal center with adjacent retinal thickening
• Retinal thickening ≥ 1 disc area, any part within 1 disc diameter of fovea

Fundus Photograph — Non-Proliferative Diabetic Retinopathy

3. Lens Changes

a. Metabolic (Snowflake / True Diabetic) Cataract

• Seen in young, poorly controlled diabetics (Type 1)
• Bilateral, rapidly progressive
• Subcapsular white snowflake opacities that may progress to complete opacification within days–weeks
• Pathogenesis: Accumulation of sorbitol via aldose reductase → osmotic swelling of lens fibers → disruption of Na⁺/K⁺ ATPase pump

b. Senile Cataract — Earlier Onset

• Posterior subcapsular cataract (PSC) more common in diabetics
• Develops 10–15 years earlier than in non-diabetics (Zia & Datta)

c. Refractive Changes (Transient)

• Myopic shift in hyperglycemia (lens swells due to sorbitol accumulation → increased refractive index)
• Hypermetropic shift after insulin treatment (rapid normalization → lens dehydrates)
• Clinically important: avoid prescribing glasses until blood sugar is stable

4. Iris Manifestations

Rubeosis Iridis (Neovascularization of the Iris / NVI)

• New vessels grow from pupillary margin → angle → form fibrovascular membrane
• Leads to neovascular (hemorrhagic) glaucoma — characterized by markedly elevated IOP, severe pain, corneal edema, and poor visual prognosis
• Occurs in ~5% of diabetics; more common in proliferative retinopathy

Other Iris Changes

• Glycogen deposition in iris pigment epithelium → vacuolation (Khurana)
• Dilated iris capillaries — seen on fluorescein angiography
• Poor pupillary dilation — autonomic neuropathy reduces mydriasis

5. Glaucoma

6. Corneal Changes

• Reduced corneal sensitivity (neurotrophic keratopathy) due to diabetic neuropathy — poor wound healing
• Recurrent corneal erosions — basement membrane abnormalities impair epithelial adhesion
• Diabetic keratopathy — reduced endothelial cell count, decreased pump function
• Increased susceptibility to infections (fungal, bacterial keratitis)

7. Optic Nerve Manifestations

Diabetic Papillopathy

• Transient, unilateral/bilateral disc swelling
• Young Type 1 diabetics, good visual prognosis
• Mild visual field changes; not related to ischemia
• Differentiates from anterior ischemic optic neuropathy (AION) by mild dysfunction and good recovery

Anterior Ischemic Optic Neuropathy (AION)

• Diabetics have increased incidence of non-arteritic AION
• Sudden, painless visual field loss (altitudinal defect) and disc edema
• (Lee et al., Ophthalmology 2011 — cited in AAO, p. 107)

8. Extraocular Muscle Palsies (Diabetic Cranial Neuropathy)

• Caused by vasa nervorum ischemia
• Pupil-sparing CN III palsy is pathognomonic for ischemic (diabetic) etiology and must be distinguished from compressive CN III palsy (pupil involved) (Kanski)
• Spontaneous recovery in 3–6 months with glycemic control

9. Other Ocular Manifestations

• Vitreous changes: Asteroid hyalosis more common in diabetics; vitreous liquefaction; premature posterior vitreous detachment (PVD)
• Lipemia retinalis: Milky-white retinal vessels due to gross hypertriglyceridemia associated with poorly controlled DM
• Autonomic neuropathy: Reduced lacrimation, Adie's tonic pupil-like changes, poor accommodation
• Increased risk of infections: Orbital cellulitis, mucormycosis (especially in ketoacidotic patients)

Pathogenesis Summary (Khurana / Zia & Datta)

Chronic hyperglycemia
        ↓
Polyol pathway activation (sorbitol ↑) → Osmotic damage
Advanced Glycation End Products (AGEs) → Basement membrane thickening
PKC activation → Increased vascular permeability, VEGF upregulation
Oxidative stress → Pericyte loss → Capillary weakness
        ↓
Microaneurysms → Hemorrhages → Exudates → Ischemia
        ↓
VEGF ↑ → Neovascularization → PDR / NVG

Screening Guidelines

Management Summary

Key Points to Remember

1. Microaneurysm = earliest clinical sign of DR
2. Hard exudates = lipid deposits, circinate around leaking vessels
3. Cotton wool spots = NFL infarcts (not true exudates)
4. 4-2-1 rule = defines severe NPDR with ~50% risk of PDR within 1 year
5. Pupil-sparing CN III = diabetic (ischemic) palsy until proven otherwise
6. Snowflake cataract = pathognomonic for young diabetics (Type 1)
7. Rubeosis iridis → neovascular glaucoma = most feared anterior segment complication
8. Anti-VEGF is now first-line for center-involving DME (over laser)
9. Refractive changes are transient and relate to acute glycemic fluctuations
10. Lipemia retinalis = rare but dramatic sign of severe hypertriglyceridemia in DM